cytosine and metoprolol
cytosine has been researched along with metoprolol in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
De Boer, RA; Hall, AS; van der Meer, P; van der Steege, G; van Veldhuisen, DJ; Voors, AA; White, HL | 1 |
Trials
1 trial(s) available for cytosine and metoprolol
Article | Year |
---|---|
The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy.
Topics: Adrenergic beta-Antagonists; Case-Control Studies; Cohort Studies; Cytosine; Female; Follow-Up Studies; Gene Frequency; Genotype; Guanine; Heart Failure; Hospitalization; Humans; Male; Metoprolol; Middle Aged; Neovascularization, Pathologic; Placebos; Polymorphism, Genetic; Promoter Regions, Genetic; Survival Rate; Thymine; Treatment Outcome; Vascular Endothelial Growth Factor A | 2005 |